Common Stock, Value, Issued of Crinetics Pharmaceuticals, Inc. from 31 Dec 2017 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Crinetics Pharmaceuticals, Inc. quarterly Common Stock, Value, Issued in USD history and change rate from 31 Dec 2017 to 31 Mar 2024.
  • Crinetics Pharmaceuticals, Inc. Common Stock, Value, Issued for the quarter ending 31 Mar 2024 was $881,000.
Source SEC data
View on sec.gov
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Change (%)

Crinetics Pharmaceuticals, Inc. Quarterly Common Stock, Value, Issued (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $881,000 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $253,000 +$253,000 31 Dec 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $0 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q4 2018 $24,000 +$23,000 +2300% 31 Dec 2018 10-K 13 Mar 2019 2018 FY
Q3 2018 $24,000 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 $2,000 30 Jun 2018 10-Q 30 Aug 2018 2018 Q2
Q4 2017 $1,000 31 Dec 2017 10-K 13 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.